Endocrine Effects of Long-Term Calcineurin Inhibitor Use in Solid Organ Transplant Recipients

    Talia Diker‐Cohen, Idit Dotan, Bronya Calvarysky, Eyal Robenshtok
    Studysummary The authors concluded that incorporating routine endocrinology consultations into transplant care could address CNI-related endocrine toxicities, but prospective studies are needed to assess the impact on graft and patient survival.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on academic.oup.com →
    Discuss this study in the Community →

    Research cited in this study 5

    1. The Many Faces of Calcineurin Inhibitor Toxicity—What the FK? Advances in chronic kidney disease · 2020
    2. Cutaneous Toxicities From Transplantation-Related Medications American Journal of Transplantation · 2017
    3. Re-Evaluating Cyclosporine A as a Hair Growth–Promoting Agent in Human Scalp Hair Follicles Journal of Investigative Dermatology · 2015
    4. Does Cyclosporin A Influence Sex Hormone Level? Experimental and Clinical Endocrinology & Diabetes · 2009
    5. Cyclosporin A-Induced Hair Growth in Mice Is Associated with Inhibition of Calcineurin-Dependent Activation of NFAT in Follicular Keratinocytes American Journal of Physiology-cell Physiology · 2003